![](/documents/176177/179111/news-generic.jpg)
Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
24 Jul 2024
Success Story: Messer's investment in Tarragona, Southern Europe's leading Chemical Hub
-
21 Jul 2024
Tarek Besold, Sony AI: “We came to Barcelona because it is a city of creativity and inspiration”
-
12 Jul 2024
Catalonia and Barcelona strengthen their commitment to sustainable mobility with Chinese company Chery
-
04 Jul 2024
AQ Compute has started the construction of a new data center in Barcelona